SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-19-002853
Filing Date
2019-11-21
Accepted
2019-11-21 16:48:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da112466002_11212019.htm SC 13D/A 77079
  Complete submission text file 0000921895-19-002853.txt   78304
Mailing Address 6 HACHOSHLIM ST. HERZELIA L3 4672406
Business Address
Arkin Moshe (Filed by) CIK: 0001321178 (see all company filings)

Type: SC 13D/A

Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89137 | Film No.: 191237874
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences